Caroline Stokke

• Blakkisrud, Johan; Peterson, Avery B.; Wildermann, Scott J.; Kingkiner, Griffen; Wong, Ka Kit & Wang, Chang [Show all 9 contributors for this article] (2024). SPECT/CT Image-Derived Absorbed Dose to Red Marrow Correlates with Hematologic Toxicity in Patients Treated with [¹⁷⁷Lu]Lu-DOTATATE. Journal of Nuclear Medicine. ISSN 0161-5505. 65(5), p. 753–760. doi: 10.2967/jnumed.123.266843.
• Stokke, Caroline; Gnesin, Silvano; Tran-Gia, Johannes; Cicone, Francesco; Holm, Søren & Cremonesi, Marta [Show all 12 contributors for this article] (2024). EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials. European Journal of Nuclear Medicine and Molecular Imaging. ISSN 1619-7070. doi: 10.1007/s00259-024-06640-x.
• Peters, Steffie; Tran-Gia, Johannes; Agius, Sam; Ivashchenko, Oleksandra V.; Badel, Jean Noël & Cremonesi, Marta [Show all 13 contributors for this article] (2023). Implementation of dosimetry for molecular radiotherapy; results from a European survey. Physica Medica. ISSN 1120-1797. 117. doi: 10.1016/j.ejmp.2023.103196. Full text in Research Archive
• Ivashchenko, Oleksandra V.; O'Doherty, Jim; Hardiansyah, Deni; Cremonesi, Marta; Tran-Gia, Johannes & Hippeläinen, Eero [Show all 10 contributors for this article] (2023). Time-Activity data fitting in molecular Radiotherapy: Methodology and pitfalls. Physica Medica. ISSN 1120-1797. 117. doi: 10.1016/j.ejmp.2023.103192. Full text in Research Archive
• Kvassheim, Monika; Tornes, Anna Julie Kjøl; Juzenienne, Asta; Stokke, Caroline & Rootwelt-Revheim, Mona Elisabeth (2023). Imaging of 212Pb in mice with a clinical SPECT/CT. EJNMMI Physics. ISSN 2197-7364. 10(1), p. 1–11. doi: 10.1186/s40658-023-00571-6. Full text in Research Archive
• Nørgaard, Jakob Nordberg; Abildgaard, Niels; Lysén, Anna Karin Christina; Tsykunova, Galina; Vangsted, Annette Juul & João, Cristina [Show all 13 contributors for this article] (2023). Intensifying treatment in PET-positive multiple myeloma patients after upfront autologous stem cell transplantation. Leukemia. ISSN 0887-6924. 37, p. 2107–2114. doi: 10.1038/s41375-023-01998-7.
• Afroz, Susmita; Østerås, Bjørn Helge; Thevathas, Utheya Salini; Døhlen, Gaute; Stokke, Caroline & Robsahm, Trude Eid [Show all 7 contributors for this article] (2023). Use of ionizing radiation in a Norwegian cohort of children with congenital heart disease: imaging frequency and radiation dose for the Health Effects of Cardiac Fluoroscopy and Modern Radiotherapy in Pediatrics (HARMONIC) study. Pediatric Radiology. ISSN 0301-0449. 53, p. 2502–2514. doi: 10.1007/s00247-023-05774-8. Full text in Research Archive Show summary

  Background: The European-funded Health Effects of Cardiac Fluoroscopy and Modern Radiotherapy in Pediatrics (HAR- MONIC) project is a multicenter cohort study assessing the long-term effects of ionizing radiation in patients with congenital heart disease. Knowledge is lacking regarding the use of ionizing radiation from sources other than cardiac catheterization in this cohort. Objective: This study aims to assess imaging frequency and radiation dose (excluding cardiac catheterization) to patients from a single center participating in the Norwegian HARMONIC project. Materials and methods: Between 2000 and 2020, we recruited 3,609 patients treated for congenital heart disease (age < 18 years), with 33,768 examinations categorized by modality and body region. Data were retrieved from the radiology information system. Effective doses were estimated using International Commission on Radiological Protection Publication 60 conversion factors, and the analysis was stratified into six age categories: newborn; 1 year, 5 years, 10 years, 15 years, and late adolescence. Results: The examination distribution was as follows: 91.0% conventional radiography, 4.0% computed tomography (CT), 3.6% diagnostic fluoroscopy, 1.2% nuclear medicine, and 0.3% noncardiac intervention. In the newborn to 15 years age cat- egories, 4–12% had ≥ ten conventional radiography studies, 1–8% underwent CT, and 0.3–2.5% received nuclear medicine examinations. The median effective dose ranged from 0.008–0.02 mSv and from 0.76–3.47 mSv for thoracic conventional radiography and thoracic CT, respectively. The total effective dose burden from thoracic conventional radiography ranged between 28–65% of the dose burden from thoracic CT in various age categories (40% for all ages combined). The median effective dose for nuclear medicine lung perfusion was 0.6–0.86 mSv and for gastrointestinal fluoroscopy 0.17–0.27 mSv. Because of their low frequency, these procedures contributed less to the total effective dose than thoracic radiography. Conclusion This study shows that CT made the largest contribution to the radiation dose from imaging (excluding cardiac intervention). However, although the dose per conventional radiograph was low, the large number of examinations resulted in a substantial total effective dose. Therefore, it is important to consider the frequency of conventional radiography while calculating cumulative dose for individuals. The findings of this study will help the HARMONIC project to improve risk assessment by minimizing the uncertainty associated with cumulative dose calculations

• Mikalsen, Lars Tore Gyland; Kvassheim, Monika & Stokke, Caroline (2023). Optimized SPECT Imaging of 224Ra α-Particle Therapy by 212Pb Photon Emissions. Journal of Nuclear Medicine. ISSN 0161-5505. 64(7), p. 1131–1137. doi: 10.2967/jnumed.122.264455. Full text in Research Archive
• Gear, Jonathan; Stokke, Caroline; Terwinghe, Christelle; Gnesin, Silvano; Sandström, Mattias & Tran-Gia, Johannes [Show all 13 contributors for this article] (2023). EANM enabling guide: how to improve the accessibility of clinical dosimetry. European Journal of Nuclear Medicine and Molecular Imaging. ISSN 1619-7070. 50(7), p. 1861–1868. doi: 10.1007/s00259-023-06226-z. Full text in Research Archive
• Bruvoll, Ragnar Bjørn Watte; Blakkisrud, Johan; Mikalsen, Lars Tore Gyland; Connelly, James Pattrick & Stokke, Caroline (2023). Correlations between 68Ga]Ga-DOTA-TOC Uptake and Absorbed Dose from [177Lu]Lu-DOTA-TATE. Cancers. ISSN 2072-6694. 15(4). doi: 10.3390/cancers15041134. Full text in Research Archive
• Cicone, Francesco; Santo, Giulia; Bodet-Milin, Caroline; Cascini, Giuseppe Lucio; Kraeber-Bodéré, Françoise & Stokke, Caroline [Show all 7 contributors for this article] (2023). Radioimmunotherapy of Non-Hodgkin B-cell Lymphoma: An update. Seminars in nuclear medicine. ISSN 0001-2998. 53(3), p. 413–425. doi: 10.1053/j.semnuclmed.2022.12.006. Show summary

  Systemic radioimmunotherapy (RIT) is arguably the most effective and least toxic anticancer treatment for non-Hodgkin lymphoma (NHL). In treatment-naïve patients with indolent NHL, the efficacy of a single injection of RIT compares with that of multiple cycles of combination chemotherapy. However, 20 years following the approval of the first CD20-targeting radioimmunoconjugates 90Y-Ibritumomab-tiuxetan (Zevalin) and 131I-tositumomab (Bexxar), the number of patients referred for RIT in western countries has dramatically decreased. Notwithstanding this, the development of RIT has continued. Therapeutic targets other than CD20 have been identified, new vector molecules have been produced allowing for faster delivery of RIT to the target, and innovative radionuclides with favorable physical characteristics such as alpha emitters have been more widely available. In this article, we reviewed the current status of RIT in NHL, with particular focus on recent clinical and preclinical developments.

• Grønningsæter, Simen Rykkje; Blakkisrud, Johan; Selboe, Silje; Rootwelt-Revheim, Mona Elisabeth; Bruland, Øyvind & Bønsdorff, Tina Bjørnlund [Show all 8 contributors for this article] (2023). Radiation safety considerations for the use of radium-224-calciumcarbonate-microparticles in patients with peritoneal metastasis. Frontiers in medicine. ISSN 2296-858X. 10, p. 1–10. doi: 10.3389/fmed.2023.1058914. Full text in Research Archive
• Larsen, Camilla Kjellstad; Galli, Elena; Duchenne, Jürgen; Aalen, John; Stokke, Caroline & Fjeld, Jan Gunnar [Show all 19 contributors for this article] (2022). Scar imaging in the dyssynchronous left ventricle: Accuracy of myocardial metabolism by positron emission tomography and function by echocardiographic strain. International Journal of Cardiology. ISSN 0167-5273. 372, p. 122–129. doi: 10.1016/j.ijcard.2022.11.042. Full text in Research Archive
• Kvassheim, Monika; Rootwelt-Revheim, Mona Elisabeth & Stokke, Caroline (2022). Quantitative SPECT/CT imaging of lead-212: a phantom study. EJNMMI Physics. ISSN 2197-7364. 9(1). doi: 10.1186/s40658-022-00481-z. Show summary

  Background Lead-212 (212Pb) is a promising radionuclide for targeted therapy, as it decays to α-particle emitter bismuth-212 (212Bi) via β-particle emission. This extends the problematic short half-life of 212Bi. In preparation for upcoming clinical trials with 212Pb, the feasibility of quantitative single photon-emission computed tomography/computed tomography (SPECT/CT) imaging of 212Pb was studied, with the purpose to explore the possibility of individualised patient dosimetric estimation. Results Both acquisition parameters (combining two different energy windows and two different collimators) and iterative reconstruction parameters (varying the iterations x subsets between 10 × 1, 15 × 1, 30 × 1, 30 × 2, 30 × 3, 30 × 4, and 30 × 30) were investigated to evaluate visual quality and quantitative uncertainties based on phantom images. Calibration factors were determined using a homogeneous phantom and were stable when the total activity imaged exceeded 1 MBq for all the imaging protocols studied, but they increased sharply as the activity decayed below 1 MBq. Both a 20% window centred on 239 keV and a 40% window on 79 keV, with dual scatter windows of 5% and 20%, respectively, could be used. Visual quality at the lowest activity concentrations was improved with the High Energy collimator and the 79 keV energy window. Fractional uncertainty in the activity quantitation, including uncertainties from calibration factors and small volume effects, in spheres of 2.6 ml in the NEMA phantom was 16–21% for all protocols with the 30 × 4 filtered reconstruction except the High Energy collimator with the 239 keV energy window. Quantitative analysis was possible both with and without filters, but the visual quality of the images improved with a filter. Conclusions Only minor differences were observed between the imaging protocols which were all determined suitable for quantitative imaging of 212Pb. As uncertainties generally decreased with increasing iterative updates in the reconstruction and recovery curves did not converge with few iterations, a high number of reconstruction updates are recommended for quantitative imaging.

• Stokke, Caroline; Nørgaard, Jakob Nordberg; Feiring Phillips, Hilde; Sherwani, Alexander Gul; Nuruddin, Syed Mohammad & Connelly, James Pattrick [Show all 8 contributors for this article] (2022). Comparison of [18F]fluciclovine and [18F]FDG PET/CT in Newly Diagnosed Multiple Myeloma Patients. Molecular Imaging and Biology. ISSN 1536-1632. 24(5), p. 842–851. doi: 10.1007/s11307-022-01734-0. Full text in Research Archive
• Løndalen, Ayca; Blakkisrud, Johan; Rootwelt-Revheim, Mona Elisabeth; Dahle, Jostein; Kolstad, Arne & Stokke, Caroline (2022). FDG PET/CT and Dosimetric Studies of 177Lu-Lilotomab Satetraxetan in a First-in-Human Trial for Relapsed Indolent non-Hodgkin Lymphoma—Are We Hitting the Target? Molecular Imaging and Biology. ISSN 1536-1632. p. 807–817. doi: 10.1007/s11307-022-01731-3. Full text in Research Archive
• Stokke, Caroline; Kvassheim, Monika & Blakkisrud, Johan (2022). Radionuclides for Targeted Therapy: Physical Properties. Molecules. ISSN 1431-5157. 27(17), p. 1–20. doi: 10.3390/molecules27175429. Full text in Research Archive
• Sjögreen Gleisner, Katarina; Chouin, Nicolas; Gabina, Pablo Minguez; Cicone, Francesco; Gnesin, Silvano & Stokke, Caroline [Show all 12 contributors for this article] (2022). EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands. European Journal of Nuclear Medicine and Molecular Imaging. ISSN 1619-7070. 49, p. 1778–1809. doi: 10.1007/s00259-022-05727-7. Full text in Research Archive
• Rootwelt-Revheim, Mona Elisabeth; Stokke, Caroline; Nørgaard, Jakob Nordberg; Phillips, Hilde Feiring; Sherwani, Alexander Gul & Schjesvold, Fredrik Hellem [Show all 7 contributors for this article] (2021). New Targets for PET Imaging of Myeloma. Hemato. ISSN 2673-6357. 2(4), p. 727–738. doi: 10.3390/hemato2040049.
• Chiesa, Carlo; Sjogreen-Gleisner, Katarina; Walrand, Stephan; Strigari, Lidia; Flux, Glenn & Gear, Jonathan [Show all 10 contributors for this article] (2021). EANM dosimetry committee series on standard operational procedures: a unified methodology for 99mTc-MAA pre- and 90Y peri-therapy dosimetry in liver radioembolization with 90Y microspheres. EJNMMI Physics. ISSN 2197-7364. 8, p. 1–44. doi: 10.1186/s40658-021-00394-3.
• Müller, Ebba Gløersen; Edwin, Trine Holt; Strand, Bjørn Heine; Stokke, Caroline; Rootwelt-Revheim, Mona Elisabeth & Knapskog, Anne Brita (2021). Is Amyloid Burden Measured by ¹⁸F-Flutemetamol PET Associated with Progression in Clinical Alzheimer's Disease? Journal of Alzheimer's Disease. ISSN 1387-2877. 85(1), p. 197–205. doi: 10.3233/jad-215046.
• Müller, Ebba Gløersen; Stokke, Caroline; Stokmo, Henning Langen; Edwin, Trine Holt; Knapskog, Anne Brita & Rootwelt-Revheim, Mona Elisabeth (2021). Evaluation of semi-quantitative measures of 18F-Flutemetamol PET for the clinical diagnosis of Alzheimer’s disease. Quantitative Imaging in Medicine and Surgery (QIMS). ISSN 2223-4292. 12(1). doi: 10.21037/qims-21-188. Full text in Research Archive
• Blakkisrud, Johan; Løndalen, Ayca; Dahle, Jostein; Martinsen, Anne Catrine Trægde; Kolstad, Arne & Stokke, Caroline (2021). Myelosuppression in patients treated with 177Lutetium-lilotomab satetraxetan can be predicted with absorbed dose to the red marrow as the only variable. Acta Oncologica. ISSN 0284-186X. 60(11), p. 1481–1488. doi: 10.1080/0284186X.2021.1959635. Full text in Research Archive
• Degtiarova, Ganna; Claus, Piet; Duchenne, Jürgen; Bogaert, Jan; Nuyts, Johan & Vöros, Gabor [Show all 15 contributors for this article] (2021). Left ventricular regional glucose metabolism in combination with septal scar extent identifies CRT responders. European Journal of Nuclear Medicine and Molecular Imaging. ISSN 1619-7070. p. 1–10. doi: 10.1007/s00259-020-05161-7.
• Larsen, Camilla Kjellstad; Aalen, John; Stokke, Caroline; Fjeld, Jan Gunnar; Kongsgård, Erik & Duchenne, Jürgen [Show all 11 contributors for this article] (2020). Regional myocardial work by cardiac magnetic resonance and non-invasive left ventricular pressure: A feasibility study in left bundle branch block. European Heart Journal-Cardiovascular Imaging. ISSN 2047-2404. 21(2), p. 143–153. doi: 10.1093/ehjci/jez231.
• Kolstad, Arne; Illidge, Tim; Bolstad, Nils; Spetalen, Signe; Madsbu, Ulf Erik & Stokke, Caroline [Show all 19 contributors for this article] (2020). Phase 1/2a study of 177Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma. Blood Advances. ISSN 2473-9529. 4(17), p. 4091–4101. doi: 10.1182/bloodadvances.2020002583. Show summary

  For patients with indolent non-Hodgkin lymphoma who fail initial anti-CD20-based immunochemotherapy or develop relapsed or refractory disease, there remains a significant unmet clinical need for new therapeutic approaches to improve outcomes and quality of life. 177Lu-lilotomab satetraxetan is a next-generation single-dose CD37-directed radioimmunotherapy (RIT) which was investigated in a phase 1/2a study in 74 patients with relapsed/refractory indolent non-Hodgkin B-cell lymphoma, including 57 patients with follicular lymphoma (FL). To improve targeting of 177Lu-lilotomab satetraxetan to tumor tissue and decrease hematologic toxicity, its administration was preceded by the anti-CD20 monoclonal antibody rituximab and the "cold" anti-CD37 antibody lilotomab. The most common adverse events (AEs) were reversible grade 3/4 neutropenia (31.6%) and thrombocytopenia (26.3%) with neutrophil and platelet count nadirs 5 to 7 weeks after RIT. The most frequent nonhematologic AE was grade 1/2 nausea (15.8%). With a single administration, the overall response rate was 61% (65% in patients with FL), including 30% complete responses. For FL with ≥2 prior therapies (n = 37), the overall response rate was 70%, including 32% complete responses. For patients with rituximab-refractory FL ≥2 prior therapies (n = 21), the overall response rate was 67%, and the complete response rate was 24%. The overall median duration of response was 13.6 months (32.0 months for patients with a complete response). 177Lu-lilotomab satetraxetan may provide a valuable alternative treatment approach in relapsed/refractory non-Hodgkin lymphoma, particularly in patients with comorbidities unsuitable for more intensive approaches. This trial was registered at www.clinicaltrials.gov as #NCT01796171.

• Løndalen, Ayca; Blakkisrud, Johan; Rootwelt-Revheim, Mona-Elisabeth; Madsbu, Ulf Erik; Dahle, Jostein & Kolstad, Arne [Show all 7 contributors for this article] (2020). FDG PET/CT parameters and correlations with tumor-absorbed doses in a phase 1 trial of 177Lu-lilotomab satetraxetan for treatment of relapsed non-Hodgkin lymphoma. European Journal of Nuclear Medicine and Molecular Imaging. ISSN 1619-7070. p. 1–13. doi: 10.1007/s00259-020-05098-x. Full text in Research Archive
• Gear, Jonathan; Chiesa, Carlo; Lassmann, Michael; Gabiña, Pablo Mínguez; Tran-Gia, Johannes & Stokke, Caroline [Show all 7 contributors for this article] (2020). EANM Dosimetry Committee series on standard operational procedures for internal dosimetry for 131I mIBG treatment of neuroendocrine tumours. EJNMMI Physics. ISSN 2197-7364. 7(1), p. 1–21. doi: 10.1186/s40658-020-0282-7.
• Müller, Ebba Gløersen; Edwin, Trine Holt; Stokke, Caroline; Navelsaker, Sigrid Stensby; Babovic, Almira & Bogdanovic, Nenad [Show all 8 contributors for this article] (2019). Amyloid-β PET—Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer´s disease diagnosis in a memory clinic. PLOS ONE. ISSN 1932-6203. 14(8), p. 1–15. doi: 10.1371/journal.pone.0221365. Full text in Research Archive
• Halsne, Trygve; Müller, Ebba Gløersen; Spiten, Ann-Eli; Sherwani, Alexander Gul; Mikalsen, Lars Tore G & Rootwelt-Revheim, Mona-Elisabeth [Show all 7 contributors for this article] (2018). The effect of new formulas for lean body mass on lean- body-mass-normalized SUV in oncologic 18F-FDG PET/CT. Journal of Nuclear Medicine Technology. ISSN 0091-4916. 46(3), p. 253–259. doi: 10.2967/jnmt.117.204586.
• Stokke, Caroline; Blakkisrud, Johan; Løndalen, Ayca; Dahle, Jostein; Martinsen, Anne Catrine Trægde & Holte, Harald [Show all 7 contributors for this article] (2018). Pre-dosing with lilotomab prior to therapy with 177Lu-lilotomab satetraxetan significantly increases the ratio of tumor to red marrow absorbed dose in non-Hodgkin lymphoma patients. European Journal of Nuclear Medicine and Molecular Imaging. ISSN 1619-7070. 45(7), p. 1233–1241. doi: 10.1007/s00259-018-3964-9. Full text in Research Archive
• Blakkisrud, Johan; Holtedahl, Jon Erik; Løndalen, Ayca; Dahle, Jostein; Bach-Gansmo, Tore & Holte, Harald [Show all 9 contributors for this article] (2018). Biodistribution and dosimetry results from a phase 1 trial of therapy with the antibody-Radionuclide conjugate 177Lu-Lilotomab satetraxetan. Journal of Nuclear Medicine. ISSN 0161-5505. 59(4), p. 704–710. doi: 10.2967/jnumed.117.195347. Full text in Research Archive
• Ausland, Line; Rootwelt-Revheim, Mona-Elisabeth; Skretting, Arne & Stokke, Caroline (2018). Respiratory motion during 90Yttrium PET contributes to underestimation of tumor dose and overestimation of normal liver tissue dose. Acta Radiologica. ISSN 0284-1851. 59(2), p. 132–139. doi: 10.1177/0284185117710052.
• Sjogreen Gleisner, Katarina; Spezi, Emiliano; Solný, Pavel; Gabiña, Pablo Minguez; Cicone, Francesco & Stokke, Caroline [Show all 13 contributors for this article] (2017). Variations in the practice of molecular radiotherapy and implementation of dosimetry: results from a European survey. EJNMMI Physics. ISSN 2197-7364. 4(28), p. 1–20. doi: 10.1186/s40658-017-0193-4.
• Stokke, Caroline; Gabiña, Pablo Minguez; Solný, Pavel; Cicone, Francesco; Sandström, Mattias & Gleisner, Katarina Sjögreen [Show all 17 contributors for this article] (2017). Dosimetry-based treatment planning for molecular radiotherapy: A summary of the 2017 report from the Internal Dosimetry Task Force. EJNMMI Physics. ISSN 2197-7364. 4:27, p. 1–9. doi: 10.1186/s40658-017-0194-3.
• Blakkisrud, Johan; Løndalen, Ayca Muftuler; Dahle, Jostein; Turner, Simon R.; Holte, Harald & Kolstad, Arne [Show all 7 contributors for this article] (2017). Red Marrow–Absorbed Dose for Non-Hodgkin Lymphoma Patients Treated with 177Lu-Lilotomab Satetraxetan, a Novel Anti-CD37 Antibody–Radionuclide Conjugate. Journal of Nuclear Medicine. ISSN 0161-5505. 58(1), p. 55–61. doi: 10.2967/jnumed.116.180471.
• Blakkisrud, Johan; Løndalen, Ayca Muftuler; Martinsen, Anne Catrine Trægde; Dahle, Jostein; Holtedahl, Jon Erik & Bach-Gansmo, Tore [Show all 9 contributors for this article] (2017). Tumor absorbed dose for non-Hodgkin’s lymphoma patients treated with the novel anti-CD37 antibody radionuclide conjugate 177Lu-lilotomab satetraxetan. Journal of Nuclear Medicine. ISSN 0161-5505. 58(1), p. 48–54. doi: 10.2967/jnumed.116.173922.
• Arnesen, Marius Røthe; Rekstad, Bernt Louni; Stokke, Caroline; Bruheim, Kjersti; Løndalen, Ayca Muftuler & Hellebust, Taran Paulsen [Show all 7 contributors for this article] (2016). Short-course PET based simultaneous integrated boost for locally advanced cervical cancer. Radiation Oncology. ISSN 1748-717X. 11(1). doi: 10.1186/s13014-016-0612-z.
• Rein, Idun Dale; Stokke, Caroline; Jalal, Marwa; Myklebust, June; Patzke, Sebastian & Stokke, Trond (2015). New distinct compartments in the G2 phase of the cell cycle defined by the levels of γH2AX. Cell Cycle. ISSN 1538-4101. 14(20), p. 3261–3269. doi: 10.1080/15384101.2015.1087617. Full text in Research Archive
• Fossum - Raunehaug, Solveig; Helgesen, Emily; Stokke, Caroline & Skarstad, Kirsten Jane (2014). Escherichia coli SeqA structures relocalize abruptly upon termination of origin sequestration during multifork DNA replication. PLOS ONE. ISSN 1932-6203. 9(10). doi: 10.1371/journal.pone.0110575.
• Gulliksrud, Kristine; Stokke, Caroline & Martinsen, Anne Catrine Trægde (2014). How to measure CT image quality: Variations in CT-numbers, uniformity and low contrast resolution for a CT quality assurance phantom. Physica Medica. ISSN 1120-1797. 30(4), p. 521–526. doi: 10.1016/j.ejmp.2014.01.006.
• Stokke, Caroline; Flåtten, Ingvild & Skarstad, Kirsten (2012). An Easy-To-Use Simulation Program Demonstrates Variations in Bacterial Cell Cycle Parameters Depending on Medium and Temperature. PLOS ONE. ISSN 1932-6203. 7(2). doi: 10.1371/journal.pone.0030981.
• Landsverk, Kirsti; Patzke, Sebastian; Rein, Idun Dale; Stokke, Caroline; Lyng, Heidi & De Angelis, Paula [Show all 7 contributors for this article] (2011). Three independent mechanisms for arrest in G(2) after ionizing radiation. Cell Cycle. ISSN 1538-4101. 10(5), p. 819–829. doi: 10.4161/cc.10.5.14968.
• Stokke, Caroline; Waldminghaus, Torsten & Skarstad, Kirsten (2011). Replication patterns and organization of replication forks in Vibrio cholerae. Microbiology (Reading). ISSN 1350-0872. 157, p. 695–708. doi: 10.1099/mic.0.045112-0.

View all works in Cristin

• Sjögreen-Gleisner, Katarina; Flux, Glenn; Bacher, Klaus; Chiesa, Carlo; de Nijs, Robin & Kagadis, George C. [Show all 17 contributors for this article] (2023). EFOMP policy statement NO. 19: Dosimetry in nuclear medicine therapy – Molecular radiotherapy. Physica Medica. ISSN 1120-1797. 116, p. 1–5. doi: 10.1016/j.ejmp.2023.103166. Full text in Research Archive
• Gear, Jonathan; Stokke, Caroline; Terwinghe, Christelle; Gnesin, Silvano; Sandström, Mattias & Tran‑Gia, Johannes [Show all 13 contributors for this article] (2023). Correction to: EANM enabling guide: how to improve the accessibility of clinical dosimetry (European Journal of Nuclear Medicine and Molecular Imaging, (2023), 50, 7, (1861-1868), 10.1007/s00259-023-06226-z). European Journal of Nuclear Medicine and Molecular Imaging. ISSN 1619-7070. 50(10), p. 3157–3158. doi: 10.1007/s00259-023-06304-2.
• Gabiña, Pablo Mínguez; Gleisner, Katarina Sjögreen; Cremonesi, Marta; Stokke, Caroline; Flux, Glenn & Cicone, Francesco [Show all 21 contributors for this article] (2023). Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetry. European Journal of Nuclear Medicine and Molecular Imaging. ISSN 1619-7070. 50, p. 2595–2604. doi: 10.1007/s00259-023-06215-2.
• Kvassheim, Monika; Rootwelt-Revheim, Mona Elisabeth & Stokke, Caroline (2022). Correction to: Quantitative SPECT/CT imaging of lead-212: a phantom study (EJNMMI Physics, (2022), 9, 1, (52), 10.1186/s40658-022-00481-z). EJNMMI Physics. ISSN 2197-7364. 9(1). doi: 10.1186/s40658-022-00499-3.
• Walrand, Stephan; Chiesa, Carlo; Gabina, Pablo Minguez; Chouin, Nicolas; Gear, Jonathan & Stokke, Caroline [Show all 10 contributors for this article] (2019). Re: Tumor Targeting and Three-Dimensional Voxel-Based Dosimetry to Predict Tumor Response, Toxicity, and Survival after Yttrium-90 Resin Microsphere Radioembolization in Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology. ISSN 1051-0443. 30(12), p. 2047–2048. doi: 10.1016/j.jvir.2019.08.030.
• Kataike, Mercy; Whittaker, Matt; Andersen, Hilde Kjernlie; Stokke, Caroline & Martinsen, Anne Catrine Trægde (2019). CT Image quality for five different metal artifact reduction algorithms.
• Mikalsen, Lars Tore Gyland; Arnesen, Marius Røthe; Bogsrud, Trond Velde; Dale, Einar & Stokke, Caroline (2017). Combining radioiodine and external beam radiation therapy: the potential of integrated treatment planning for differentiated thyroid cancer. Acta Oncologica. ISSN 0284-186X. doi: 10.1080/0284186X.2017.1286384.
• Blakkisrud, Johan; Løndalen, Ayca; Dahle, Jostein; Martinsen, Anne Catrine Trægde; Holthe, Harald & Kolstad, Arne [Show all 7 contributors for this article] (2017). Pre-dosing with lilotomab prior to antibody-radionuclide conjugate therapy with 177Lu-lilotomab satetraxetan significantly increases the ratio of tumour to red marrow absorbed dose in non-Hodgkin lymphoma patients.
• Blakkisrud, Johan; Løndalen, Ayca; Dahle, Jostein; Martinsen, Anne Catrine Trægde; Holthe, Harald & Kolstad, Arne [Show all 7 contributors for this article] (2017). Image-based red marrow dosimetry of multiple skeletal sites for 177Lu-Lilotomab satetraxetan patients.
• Mikalsen, Lars Tore Gyland; Arnesen, Marius R?the; Bogsrud, Trond Velde; Dale, Einar & Stokke, Caroline (2017). Combining radioiodine and external beam radiation therapy: the potential of integrated treatment planning for differentiated thyroid cancer. Acta Oncologica. ISSN 0284-186X. 56(6), p. 894–897. doi: 10.1080/0284186X.2017.1286384.
• Larsen, Camilla Kjellstad; Aalen, John; Stokke, Caroline; Fjeld, Jan Gunnar; Kongsgård, Erik & Smiseth, Otto A. [Show all 7 contributors for this article] (2016). Regional myocardial work by magnetic resonance imaging and noninvasive left ventricular pressure: a feasibility study in left bundle branch block.
• Kolstad, Arne; Madsbu, Ulf Erik; Stokke, Caroline; Bach-Gansmo, Tore & Løndalen, Ayca Muftuler (2016). Pre-dosing with unlabelled antibody significantly increases the pharmacokinetic exposure and reduces haematological toxicity of 177Lu-lilotomab in non-Hodgkin B-cell lymphoma patients.
• Stokke, Caroline; Løndalen, Ayca; Dahle, Jostein; Blakkisrud, Johan; Bach-Gansmo, Tore & Holtedahl, Jon Erik [Show all 10 contributors for this article] (2015). Tumour-Absorbed Dose for Patients in a Phase I study undergoing antibody-radionuclide-conjugate (ARC) therapy with 177Lu-DOTA-HH1.

View all works in Cristin